Trial · NCT04518995
Adverse events48
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 48
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | COVID-19 | Infections and infestations | Placebo | 8 | 140 | |
| other | COVID-19 | Infections and infestations | CTP-543 8 mg BID | 19 | 350 | |
| other | COVID-19 | Infections and infestations | CTP-543 12 mg BID | 15 | 215 | |
| other | Nasopharyngitis | Infections and infestations | Placebo | 5 | 140 | |
| other | Nasopharyngitis | Infections and infestations | CTP-543 8 mg BID | 18 | 350 | |
| other | Nasopharyngitis | Infections and infestations | CTP-543 12 mg BID | 8 | 215 | |
| other | Upper respiratory tract infection | Infections and infestations | Placebo | 9 | 140 | |
| other | Upper respiratory tract infection | Infections and infestations | CTP-543 8 mg BID | 9 | 350 | |
| other | Upper respiratory tract infection | Infections and infestations | CTP-543 12 mg BID | 8 | 215 | |
| other | Blood creatine phosphokinase (increased) | Investigations | Placebo | 2 | 140 | |
| other | Blood creatine phosphokinase (increased) | Investigations | CTP-543 8 mg BID | 21 | 350 | |
| other | Blood creatine phosphokinase (increased) | Investigations | CTP-543 12 mg BID | 11 | 215 | |
| other | Headache | Nervous system disorders | Placebo | 8 | 140 | |
| other | Headache | Nervous system disorders | CTP-543 8 mg BID | 41 | 350 | |
| other | Headache | Nervous system disorders | CTP-543 12 mg BID | 24 | 215 | |
| other | Acne | Skin and subcutaneous tissue disorders | Placebo | 7 | 140 | |
| other | Acne | Skin and subcutaneous tissue disorders | CTP-543 8 mg BID | 31 | 350 | |
| other | Acne | Skin and subcutaneous tissue disorders | CTP-543 12 mg BID | 26 | 215 | |
| serious | Appendicitis | Infections and infestations | Placebo | 1 | 140 | |
| serious | Appendicitis | Infections and infestations | CTP-543 8 mg BID | 1 | 350 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04518995/events